Innovating
Healthcare,
Inspiring Trust

An East African pharmaceutical manufacturer delivering high-quality, clinically relevant medicines to Ethiopia and the world. Manufactured to EFDA cGMP standards.

EFDA cGMP Certified

Manufactured to Ethiopian Food and Drug Authority current Good Manufacturing Practice standards.

EU Qualified Pharmacist Audit

Independently audited by a European Union Qualified Pharmacist.

Four ISO Certifications

ISO 9001 · ISO 14001 · ISO 45001 · ISO 27001

600M
Tablets / Year
7M
Bottles / Year
70+
Products
8
Therapeutic Areas
·EFDA cGMP
·ISO 9001:2015
·ISO 14001:2015
·ISO 45001:2018
·ISO 27001:2013
Why Glocare

What Makes Us Different

Four pillars that define our approach to pharmaceutical manufacturing and set us apart.

Clinical Relevance & Innovation

Products designed around genuine clinical need not just market trends. Our team of medical doctors guides portfolio decisions with patient outcomes at the centre.

Bioavailability / Bioequivalence

Multiple products carry bioequivalence certification, ensuring therapeutic performance is proven and consistent not assumed.

Stable, Reliable Supply

Vertically integrated operations from a state-of-the-art facility ensure consistent availability, eliminating the stock-outs that plague import-dependent markets.

Uncompromising Quality

EFDA cGMP certified facility with four ISO certifications. Every batch monitored, tested and validated to international standards.

Managed by Medical Doctors

Unlike typical manufacturers, Glocare is guided by physicians ensuring every product decision is grounded in therapeutic reality and patient benefit.

Long-Term Partnerships

We believe in commitment to our stakeholders. Previous management experience exporting to 40 countries building lasting relationships, not transactions.

Portfolio

Our Therapeutic Focus

Eight key areas covering the most critical healthcare needs across Ethiopia and our export markets.

Anti-Infective
Diabetes
Cardiovascular
Respiratory
Vitamins & Nutrition
Gastrointestinal
Neuropsychiatric
Pain / Inflammation
Our Story

Built for Ethiopia's Healthcare Future

Glocare Pharma was born from a vision dedicated to ensuring the health and wellbeing of communities in Ethiopia and around the world. Established in 2022 at Kilinto Industrial Park, Addis Ababa, we represent a landmark commitment to Ethiopian pharmaceutical self-sufficiency.

Our factory produces tablets and liquid medicines. Our production team has 25 years of experience in the pharmaceutical sector, with previous experience managing an EU GMP approved manufacturing facility and exporting to 40 countries across Europe, the UK, Asia, Africa, South America and CIS, with market-leading products in multiple countries.

Uniquely, Glocare is managed by medical doctors, ensuring every strategic decision is grounded in clinical reality and genuine patient need rather than commercial logic alone.

Glocare Pharma manufacturing facility, Kilinto Industrial Park, Addis Ababa
2022

Inaugurated March 2022

The Challenge

The Ethiopian Pharmaceutical Sector

The Situation

80–85% of pharmaceuticals in Ethiopia are imported. Very few local manufacturers exist. The country of 130+ million people, the second-largest population in Africa,and the country is highly dependent on fragile external supply chains.

The Result

Frequent stock-outs and no supply continuity. Inconsistent quality across different imports. Significant gaps in availability of clinically advanced medications for Ethiopian patients.

What Ethiopia Needs

Consistent quality. Reliable local supply. Clinically relevant, advanced medications. Glocare exists to meet all three. We are committed to helping build a self-sufficient pharmaceutical sector.

Our Journey

Glocare Milestones

20
Mar 2020
Construction Start
21
Feb 2021
EFDA Design Approved
21
Sep 2021
Manufacturing License Application
22
Jun 2022
Manufacturing License Approved
22
Aug 2022
EU-QP Audit Team Visited
22
Dec 2022
ISO Audit & Certification
23
Jan 2023
EFDA cGMP Audit
2023
EFDA cGMP Certification Received
Our Edge

What Makes Us Different

Clinical Relevance & Innovation

Products chosen for genuine therapeutic value. Our medical doctor management ensures clinical priorities, not just commercial ones, drive the portfolio.

Bioavailability / Bioequivalence

Multiple products carry bioequivalence certification, with proven therapeutic performance rather than assumed equivalence. This is rare in the local market.

Stable, Reliable Supply

Local manufacture means we can guarantee continuity that imported products cannot. No supply chain disruptions, no stock-outs.

Uncompromising Quality

EFDA cGMP certified with four ISO certifications. Quality is our operating standard, not a checkbox.

Managed by Medical Doctors

Physician-led management brings clinical thinking to every product decision from portfolio selection to packaging and labelling standards.

Global Export Experience

Our team brings experience exporting to 40 countries across Europe, UK, Asia, Africa, South America, and CIS bringing proven global standards home to Ethiopia.

Product Portfolio

Medicines That Matter

A comprehensive range of high-quality essential medicines across 8 therapeutic categories, manufactured to USP and BP standards at our EFDA cGMP certified facility.

Flagship Products

Featured Brands

Nine of our most clinically differentiated products, chosen for their therapeutic relevance and proven quality.

Therapeutic Areas

Our Product Segments

We manufacture across eight therapeutic categories, covering the most prevalent healthcare needs in Ethiopia and our export markets. All products are manufactured to USP or BP standards at our EFDA cGMP certified facility.

Anti-Infective

Antibacterial, Antimalarial & Antiparasitic

A broad range covering fluoroquinolones, macrolides, combination antiparasitic therapies and antimalarials. Multiple products carry bioequivalence certification.

Diabetes

Glycaemic Management

From metformin monotherapy through to the clinically advanced DPP-4 inhibitor combination Gal Nex, our diabetes portfolio addresses the full spectrum of Type 2 management needs.

Cardiovascular

Hypertension, Dyslipidaemia & Heart Failure

Statins, calcium channel blockers, ACE inhibitors, ARBs, beta-blockers and diuretics covering the principal agents in cardiovascular risk management.

Respiratory & Allergy

Bronchodilators, Antihistamines & Expectorants

Tablets and liquid oral formulations covering bronchospasm, allergic rhinitis, cough and upper respiratory infection in both adult and paediatric presentations.

Vitamins & Nutrition

Nutritional Supplementation & Iron Tonics

Liquid oral formulations including our flagship Aminovit Gold and G-Vit Syrup, plus Feramin iron tonic, addressing nutritional deficiencies across all age groups.

Neuropsychiatric

Antipsychotics & Antidepressants

Haloperidol, olanzapine, chlorpromazine and amitriptyline, addressing psychosis, mood disorders and chronic psychiatric conditions where consistent local supply is critical.

Gastrointestinal

PPIs & Antispasmodics

Esomeprazole and hyoscine butylbromide addressing acid-related disorders and gastrointestinal spasm, among the most frequently prescribed medicines in general practice.

Pain & Inflammation

Analgesics & NSAIDs

Paracetamol, ibuprofen and diclofenac in tablet and oral suspension forms, with bioequivalence certification on key products for full therapeutic confidence.

70+ products across all eight therapeutic areas
For a full product list, reach out to our business development team directly.
Our Facility

World-Class Manufacturing

Located at Kilinto Industrial Park, Addis Ababa Ethiopia's premier government-promoted pharmaceutical hub. Designed for precision, scale, and international compliance.

Capabilities

Production Capabilities

High-Speed Tablet Production

Sophisticated RMG, high-speed double rotary tablet compression (auto reject), fluidized bed dryers, and auto coater. Capacity of over 1 million tablets per shift. Capable of uncoated, enteric coated, sugar coated, and film coated tablets.

Liquid Orals

Automatic filling machines producing large volumes of liquid orals. HEPA filters installed in both manufacturing and filling areas. Products offered in both glass and PET bottles.

Analytical Laboratory

Equipped with HPLC, IR double beam spectrometers, TLC, fluorometers and more capable of performing all necessary chemical and microbiological assays.

600M
Tablets / Year
7M
Bottles / Year
70+
Products
Granulation suite — RMG, sifter and fluid-bed dryer
High-speed rotary tablet compression
Automatic capsule filling line with metal detection
Octagonal blender for uniform powder mixing
Automated film-coating system
Certifications

Our Certifications

Every certification represents a rigorous third-party audit and a commitment to maintaining international manufacturing standards.

EFDA cGMP

EFDA current Good Manufacturing Practice, the global gold standard for pharmaceutical manufacturing quality.

ISO 9001:2015

Quality Management System certification covering all aspects of our production and operational quality control processes.

ISO 14001:2015

Environmental Management System demonstrating our commitment to responsible, sustainable manufacturing practices.

ISO 45001:2018

Occupational Health & Safety Management System ensuring the wellbeing and safety of our workforce at all times.

ISO 27001:2013

Information Security Management System protecting our proprietary formulation data and customer information.

EU QP Audited

Independently audited by a European Union Qualified Pharmacist, aligning our processes with European manufacturing standards.

Looking Ahead

Future Expansion Factory

We are investing in a major new factory expansion that will dramatically broaden our production capabilities and more than double our current output positioning Glocare as a comprehensive pharmaceutical manufacturer serving the full range of dosage form needs.

Expansion Vision

A Complete Manufacturing Platform

Our new factory will add five entirely new production lines alongside dramatically expanded existing capacity enabling Glocare to serve a far wider range of therapeutic and dosage form needs, both locally and for export.

Tablet Capacity
Liquid Capacity
5
New Lines
+
Export Markets

New Production Lines

Capsule Line

A dedicated hard gelatin capsule manufacturing line enabling a new dosage form, significantly expanding the range of therapeutic categories and molecules we can bring to market.

Sachet Line

A sachet manufacturing line for powder and granule presentations, opening important product categories including ORS, nutritional supplements, and single-dose medicines for paediatric and rural markets.

Semisolids Line

A dedicated semisolids manufacturing line for creams, gels, and ointments, addressing dermatological, topical anti-inflammatory, and antifungal needs that currently go entirely unserved by local production.

LVP Line

A Large Volume Parenteral (LVP) line for IV fluids and infusion solutions. This is one of the most critical unmet needs in Ethiopian hospitals and a major import category we will be able to supply locally.

Expanded Tablet & Liquid Lines

Both our existing tablet and liquid oral lines will be doubled in capacity, bringing our combined production capability to over 1.2 billion tablets and 14 million liquid bottles per year.

Capacity: Current vs. Future

Current Facility
Tablets600M / year
Liquid Orals7M bottles / year
Dosage forms: Tablets + Liquid Orals
Future Expansion Factory
Tablets1.2B+ / year
Liquid Orals14M+ bottles / year
Dosage forms: Tablets · Liquid Orals · Capsules · Sachets · Semisolids · LVP
Standards & Compliance

Quality is Our Foundation

Every product, every batch, every day monitored by a dedicated quality control department using computer-controlled test equipment to the highest international standards.

01

EFDA cGMP Certified

Our facility meets Ethiopian Food and Drug Authority current Good Manufacturing Practice standards, the benchmark for international pharmaceutical quality assurance.

  • ISO 9001:2015 Quality Management
  • ISO 14001:2015 Environmental
  • ISO 45001:2018 Occupational Safety
  • ISO 27001:2013 Information Security
  • EFDA cGMP — Ethiopian Food and Drug Authority
02

EU Qualified Pharmacist Audit

Our facility has been audited by a European Union Qualified Pharmacist (QP). This is one of the most rigorous independent pharmaceutical manufacturing assessments available globally.

  • Full EU manufacturing standards review
  • Independent third-party QP assessment
  • Confirms compliance with EU GMP expectations
  • Supports export readiness to European markets
03

Quality Control

A separate quality assurance team monitors the entire production process with validation of areas, processes, equipment and systems.

  • Computer-controlled testing at every checkpoint
  • HPLC, IR spectrometers, TLC, fluorometers
  • Full chemical and microbiological assay capability
  • ERP-integrated compliant ERP system
  • Rigorous raw material testing at goods-in stage
04

Building Management System

Environmental monitoring sensors calibrated to measure temperature, humidity and pressure across all classified manufacturing areas in real-time.

  • Continuous environmental monitoring
  • Automated deviation alarms and escalation
  • Recorded readings for full traceability
  • Immediate action protocols on deviations
Pharmacovigilance

Committed to Product Safety

Pharmacovigilance is an essential part of our quality commitment. Our ongoing processes allow for feedback to be received and acted upon in a timely and efficient manner.

Our dedicated pharmacovigilance system ensures that any adverse events or product quality concerns are captured, investigated, and resolved protecting patients and maintaining the trust of our healthcare partners worldwide.

Pharmacovigilance Process

01
Signal Detection

Continuous monitoring of product performance and adverse event reports from healthcare partners and patients.

02
Assessment & Evaluation

Medical and scientific review of all signals to assess causality and clinical significance.

03
Risk Management

Implementation of appropriate risk minimisation measures where required.

04
Communication

Timely reporting to regulatory authorities and transparent communication with stakeholders.

Our Reach

Rooted in Ethiopia, Built for the World

From our Kilinto base, we are contributing to Ethiopia's pharmaceutical self-sufficiency while building export capability across global markets.

Global Export Ready

Serving markets across Africa, Asia, Europe and beyond

East Africa West Africa South Asia Middle East Europe Asia Pacific CIS South America
80%

Import Reduction Opportunity

80–85% of Ethiopia's pharmaceuticals are currently imported. Glocare is positioned to be a key part of the national goal to dramatically reduce this dependency.

40

Countries of Export Experience

Our management team brings proven experience exporting to 40 countries across Europe, the UK, Asia, Africa, South America, and CIS, with market-leading products in multiple countries.

25yr

Sector Experience

Our production team has 25 years of experience in the pharmaceutical sector, including managing an EU GMP approved manufacturing facility.

Our Vision

A Future of Ethiopian Pharmaceutical Excellence

We want to be a key part of the development of Ethiopia's pharmaceutical sector, and thus its healthcare outcomes. We need your support and your feedback in our growth journey.

From 85% pharmaceutical imports to under 10% in 5 years, contributing to Ethiopia's ambitious self-sufficiency goal.

A future where Ethiopians have access to cutting-edge medications manufactured locally to international standards.

Expansion of our facility to produce capsules, sachets, semisolids, LVP (large volume parenterals). It will also more than double our tablet and liquid production capacity.

Building long-term partnerships with distributors, healthcare providers, and institutions that share our commitment to patient outcomes.

Get in Touch

Partner with Glocare

Whether you are a distributor, healthcare provider, regulatory partner, or export customer, we would love to hear from you.